| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.56 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |